Study on Radiation Therapy Before CD19 CAR-T Cell Treatment for High-Risk Large B-Cell Lymphoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sponsor score: 40
ClinicalTrials ID:NCT06104592
This clinical trial is testing the safety and effectiveness of using radiation therapy before CD19 CAR-T cell treatment in patients with large B-cell lymphoma who have large tumors (5 cm or bigger).
Patient Parameters
| Parameter | Options |
|---|
Program Overview
This study aims to evaluate if using radiation therapy before CD19 CAR-T cell treatment is safe and effective for patients with large B-cell lymphoma (LBCL) who have large tumors. The trial is open to patients with tumors measuring 5 cm or more, and it will assess how well this approach works in controlling the disease.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with diffuse large B-cell lymphoma (DLBCL) and planning to receive treatment at Moffitt Cancer Center.
- Able to understand and willing to sign a consent form to participate in the study.
- Eligible for CAR T-cell therapy (axicabtagene ciloleucel) for LBCL and related types as per standard care guidelines.
- Have a performance status score of 0 to 2, indicating good overall health.
- Have at least one large tumor (5 cm or bigger) that can be targeted with radiation.
- Able to receive radiation therapy to all visible cancer sites.
- No signs of cancer in the central nervous system.
- Have adequate bone marrow and organ function as per study guidelines.
- Agree to use effective birth control methods during the study to prevent pregnancy.
- Men must take precautions to avoid fathering a child during the study.
- Women of childbearing potential must have a negative pregnancy test before starting treatment and agree to use effective birth control.
- Women who are not of childbearing potential (surgically sterile or postmenopausal for 12 months) are eligible.
Exclusion Criteria
- Currently receiving or have recently received another investigational treatment within 4 weeks before the study.
- Have had previous CAR T-cell therapy.
- Unable to safely receive radiation therapy to all cancer sites.
- Have significant heart disease or unstable heart conditions.
- Have uncontrolled or untreated infections.
- Known HIV positive status.
- Active or chronic hepatitis B infection unless viral load is undetectable with treatment.
- History of hepatitis C infection unless cleared with treatment.
- Require ongoing use of steroids or immunosuppressant medications.
- Any condition that may interfere with participation or pose a risk to the patient.
- Unlikely to complete all study visits or procedures.
- Women who are pregnant or breastfeeding. Women who are surgically sterile or postmenopausal for 12 months are not considered of childbearing potential.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Moffitt Cancer Center | 33612 | Tampa | Florida |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.
